Literature DB >> 10230618

Synthesis, aggregation, and neurotoxicity of the Alzheimer's Abeta1-42 amyloid peptide and its isoaspartyl isomers.

H Fukuda1, T Shimizu, M Nakajima, H Mori, T Shirasawa.   

Abstract

Amyloid Abeta1-42 peptide (Abeta1-42) and its isomers with an isoaspartyl residue at position 7 or 23 [Abeta1-42(isoAsp7) and Abeta1-42(isoAsp23)] were synthesized in high purity by the Fmoc-solid phase technique, followed by HPLC on a silica-based reversed-phase column under the basic conditions. Importantly, Abeta1-42(isoAsp23) aggregated more strongly than native Abeta1-42 and showed significant neurotoxicity, while the aggregation ability and neurotoxicity of Abeta1-42(isoAsp7) was weak. This suggests that the isomerization of the aspartyl residues plays an important role in fibril formation in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10230618     DOI: 10.1016/s0960-894x(99)00121-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Change of dynamics of raft-model membrane induced by amyloid-β protein binding.

Authors:  Mitushiro Hirai; Ryota Kimura; Kazuki Takeuchi; Masaaki Sugiyama; Kouji Kasahara; Noboru Ohta; Bela Farago; Andreas Stadler; Giuseppe Zaccai
Journal:  Eur Phys J E Soft Matter       Date:  2013-07-16       Impact factor: 1.890

2.  Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions.

Authors:  Nadezda P Sargaeva; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2009-12-01       Impact factor: 6.986

3.  Solid-state NMR reveals a comprehensive view of the dynamics of the flexible, disordered N-terminal domain of amyloid-β fibrils.

Authors:  Dan Fai Au; Dmitry Ostrovsky; Riqiang Fu; Liliya Vugmeyster
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

Review 4.  APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Authors:  Alex E Roher; Tyler A Kokjohn; Steven G Clarke; Michael R Sierks; Chera L Maarouf; Geidy E Serrano; Marwan S Sabbagh; Thomas G Beach
Journal:  Neurochem Int       Date:  2017-08-12       Impact factor: 3.921

5.  Effect of Post-Translational Modifications and Mutations on Amyloid-β Fibrils Dynamics at N Terminus.

Authors:  Liliya Vugmeyster; Dan F Au; Dmitry Ostrovsky; Brian Kierl; Riqiang Fu; Zhi-Wen Hu; Wei Qiang
Journal:  Biophys J       Date:  2019-09-12       Impact factor: 4.033

6.  Improved chemical synthesis of hydrophobic Aβ peptides using addition of C-terminal lysines later removed by carboxypeptidase B.

Authors:  Saketh Chemuru; Ravindra Kodali; Ronald Wetzel
Journal:  Biopolymers       Date:  2014-03       Impact factor: 2.505

7.  Distinguishing d- and l-aspartic and isoaspartic acids in amyloid β peptides with ultrahigh resolution ion mobility spectrometry.

Authors:  Xueyun Zheng; Liulin Deng; Erin S Baker; Yehia M Ibrahim; Vladislav A Petyuk; Richard D Smith
Journal:  Chem Commun (Camb)       Date:  2017-07-11       Impact factor: 6.222

8.  Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis.

Authors:  S A Kozin; I B Cheglakov; A A Ovsepyan; G B Telegin; P O Tsvetkov; A V Lisitsa; A A Makarov
Journal:  Neurotox Res       Date:  2013-05-14       Impact factor: 3.911

9.  MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.

Authors:  Bin Liu; Jeffrey L Frost; Jing Sun; Hongjun Fu; Stephen Grimes; Peter Blackburn; Cynthia A Lemere
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

Review 10.  Truncated and modified amyloid-beta species.

Authors:  Markus P Kummer; Michael T Heneka
Journal:  Alzheimers Res Ther       Date:  2014-05-26       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.